In vitro diagnostics focused on drug-resistant organisms
Total Trials
7
As Lead Sponsor
4
As Collaborator
3
Total Enrollment
10,014
NCT02060513
Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections
Phase: N/A
Role: Collaborator
Start: Aug 31, 2013
Completion: Nov 30, 2016
NCT02482051
Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
Start: Jul 31, 2015
Completion: Jan 31, 2022
NCT02796716
Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections
Completion: Dec 31, 2016
NCT02719769
Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture
Role: Lead Sponsor
Start: Jan 31, 2016
Completion: Jan 12, 2017
NCT03744728
Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures
Start: May 23, 2019
Completion: Jun 30, 2023
NCT03745014
Clinical Impact of Fast Phenotypic Antimicrobial Susceptibility Testing on Patients With Gram-Negative Rod Bacteremia
Start: Sep 30, 2019
Completion: Aug 31, 2020
NCT04295915
Clinical Performance and Reproducibility of the Accelerate PhenoTest™ Blood Culture (BC) Kit With New Antibiotic Wave I Updates
Start: Mar 11, 2020
Completion: Apr 19, 2022
Loading map...